The Company is a Korea-based company engaged in the manufacture, preparation, appraisal, import and sale of pharmaceutical products. The Company s products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, antifungal agents, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs, topical anesthetics and others. It also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, meloxicam, oxaliplatin, ramipril and others. The Company was founded on November 25, 1964 and its shares are listed on Korea Stock Exchange on June 10, 2010.
Headquarters
38-6 Dongbinggo-Dong, Yongsan-Gu
Seoul; Seoul;
Postal Code: 100-833
Contact Details: Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Website: http://reyonpharm.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service